SCHEMBL17272799

SCHEMBL17272799

COC(=O)c1cccc2s[nH]c(=O)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.45
▸ GLA P06280 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CHEK1 O14757 1/20 0.42
▸ MET P08581 1/20 0.42
▸ GSK3B P49841 1/20 0.42
▸ LIMK1 P53667 1/20 0.42
▸ DYRK1A Q13627 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.42
▸ DYRK1B Q9Y463 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ CFTR P13569 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ ATM Q13315 1/20 0.40
▸ PTPRC P08575 1/20 0.40
▸ MAPT P10636 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6007667 0.73 NR4A2 (0.53) KDM4EGLAGAAMETLMNA
SCHEMBL29022514 0.72 KMT2A (0.46) KDM4EGLAGAAMETLMNA
SCHEMBL3914627 0.71 ALOX5 (0.55) KDM4EGLAGAAMETLIMK1
SCHEMBL29576400 0.70 KDM4E (0.58) KDM4ELMNATSHRALDH1A1HSD17B10
SCHEMBL68712 0.70 KDM4E (0.58) KDM4ELMNATSHRALDH1A1HSD17B10
SCHEMBL17842946 0.70 TSHR (0.43) KDM4ECHEK1METGSK3BLIMK1
SCHEMBL29494120 0.70 MAPT (0.52) KDM4EGLAGAALMNATSHR
SCHEMBL52314 0.70 MAPT (0.52) KDM4EGLAGAALMNATSHR
SCHEMBL24704203 0.69 NR4A2 (0.54) KDM4EGLAGAALMNATSHR
SCHEMBL13293021 0.69 TSHR (0.53) KDM4ELMNATSHRALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2949650-B1 Synthetic method for the preparation of 1,2-Benzisothiazolin-3-one SHOUGUANG SYNTECH FINE CHEMICAL CO LTD (CN) 2017-10-11 — — EP disclosed
US-9334248-B2 Synthetic method for the preparation of 1, 2-benzisothiazolin-3-one SHOUGUANG SYNTECH FINE CHEMICAL CO., LTD. (CN) 2016-05-10 — — US disclosed
EP-2949650-A1 Synthetic method for the preparation of 1,2-Benzisothiazolin-3-one Shouguang Syntech Fine Chemical Co., Ltd. (CN) 2015-12-02 — — EP disclosed
US-20150336910-A1 SYNTHETIC METHOD FOR THE PREPARATION OF 1, 2-BENZISOTHIAZOLIN-3-ONE SYNTECH EURO LIMITED (GB) 2015-11-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336910-A1 SYNTHETIC METHOD FOR THE PREPARATION OF 1, 2-BENZISOTHIAZOLIN-3-ONE TST, AQP1, BZW1 KDM4E 3605/4885GLA 3618/4885GAA 4375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback